Chiara Bini
ScholarGPS® ID: 73534512808546
Affiliation History
Field
Social Sciences
Discipline
Economics
Top Specialties
Health Technology Assessment | Technology Assessment
Metrics Summary
Publication Count
20
Predicted Citations
88
Predicted h-index
5
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Farmeconomia. Health economics and therapeutic pathways, volume 24, issue 1 (2023). |
[Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life] (journal article) Farmeconomia. Health economics and therapeutic pathways, volume 24, issue 1 (2023). |
Economic evaluation of treosulfan in patients undergoing allogeneic haematopoietic stem cell transplantation (journal article) Global & Regional Health Technology Assessment, volume 9 (2022). |
Global & Regional Health Technology Assessment, volume 9 (2022). |
Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP) (journal article) Global & Regional Health Technology Assessment, volume 9 (2022). |
Evaluation of epidemiological and economic consequences due to the delay in treatment of hiv-positive patients caused by the covid-19 pandemic (journal article) Global & Regional Health Technology Assessment, volume 8 (2021). |
Cost-utility analysis of evolocumab in patients with ASCVD in Italy (journal article) Global & Regional Health Technology Assessment, volume 8 (2021). |
ost of illness del carcinoma cutaneo a cellule squamose (CSCC) (journal article) Global & Regional Health Technology Assessment, volume 7, issue 1, pages 148-153 (2020). |
PIN38 Cost-Effectiveness of Expanded HIV Screening Among Adult Population in Italy (journal article) Value in Health, volume 23 (2020). |
Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia (journal article) Global & Regional Health Technology Assessment, volume 7, issue 1, pages 92-100 (2020). |
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries (journal article) Clinical Drug Investigation, volume 40, issue 4, pages 305-318 (2020). |
Cost of illness of spinal muscular atrophy (SMA) in Italy (journal article) Global and Regional Health Technology Assessment, volume 6, issue 1 (2019). |
The economic impact of biosimilars in Italy: a scenario analysis (journal article) Global and Regional Health Technology Assessment, volume 6, issue 1 (2019). |
Cost of illness of spinal muscular atrophy (SMA) in Italy (journal article) Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, volume 2019 (2019). |
The economic impact of biosimilars in Italy: a scenario analysis (journal article) Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, volume 2019 (2019). |
Reproductive Biology and Endocrinology, volume 16, issue 1 (2018). |
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma (journal article) Clinical Drug Investigation, volume 38, issue 10, pages 967-976 (2018). |
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy (journal article) Human Vaccines & Immunotherapeutics, volume 14, issue 8, pages 1867-1873 (2018). |
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group (journal article) Global and Regional Health Technology Assessment, volume 5, issue 1 (2018). |
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group (journal article) Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, volume 2018 (2018). |